PARACETAMOL + CODEINE 1. Product Name 2. …
Use in patients with known hypersensitivity or idiosyncratic reaction to paracetamol, codeine, other opiates or any of the excipients listed in section 6.1.
Download PARACETAMOL + CODEINE 1. Product Name 2. …
Information
Domain:
Source:
Link to this page:
Documents from same domain
ADVANTAN Presentation Uses - Medsafe
www.medsafe.govt.nzADVANTAN® Data Sheet Page 1 of 9 ADVANTAN® Methylprednisolone aceponate 0.1% ointment/cream . Presentation 1 g cream or ointment contains 1 mg (0.1%) methylprednisolone aceponate.
LOXALATE 1. Product Name - Medsafe Home Page
www.medsafe.govt.nzPage 5of 21 at risk, such as the elderly, or patients with cirrhosis, or if used in combination with other medications which may cause hyponatraemia.
DATA SHEET 1 CLEXANE AND CLEXANE FORTE ... - …
www.medsafe.govt.nzNew Zealand Data Sheet June 2017 . clexane-clexane-forte-ccdsv13-dsv18-16jun17 Page 2 . 100 mg injection enoxaparin sodium 100mg (equivalent to …
SEPTANEST Articaine hydrochloride 4% with …
www.medsafe.govt.nzSEPTANEST Articaine hydrochloride 4% with adrenaline 1:100,000 Injection for local and regional dental anaesthesia DESCRIPTION SEPTANEST is a sterile aqueous solution that contains articaine hydrochloride 4% (40 mg/mL) with adrenaline acid tartrate in a 1:100,000 strength.
BOOSTRIX - Medsafe Home Page
www.medsafe.govt.nz1 BOOSTRIX®. Combined diphtheria, tetanus, acellular pertussis (dTpa) vaccine . CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET? This leaflet answers some of the common questions about BOOSTRIX vaccine.
NEW ZEALAND DATA SHEET - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET Cymevene ® DS 170831 2 of 26 Caution: Cymevene must only be administered by IV infusion over 1 hour, preferably via a
Edition Draft - Medsafe
www.medsafe.govt.nzPart 4, Ed Draft Page 2 of 9 Section 1: Good Manufacturing Practice Documentation 1.1. When is GMP Documentation Required? Medsafe requires evidence of Good Manufacturing Practice (GMP) compliance for
Data Sheet 1 PRODUCT NAME 2 QUALITATIVE AND …
www.medsafe.govt.nzNew Zealand Data Sheet 31 July 2017 Lantus – insulin glargine lantus-ccdsv19-dsv11-31jul17 Page 1 Data Sheet 1 PRODUCT NAME Lantus 100 IU/mL solution for injection in 10 …
NEW ZEALAND DATA SHEET MESTINON® - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET MESTINON® MESTINON Page 4 of 8 As the severity of myasthenia gravis often fluctuates considerably, particular care is required to
DATA SHEET PREDNISONE - Medsafe
www.medsafe.govt.nz• Epilepsy and/or seizure disorder • Peptic ulceration • Previous steroid myopathy • Tuberculosis • Patients with myasthenia gravis receiving anticholinesterase therapy since
Related documents
Potentially Harmful Drugs in the Elderly: Beers List …
fmda.orgThe Beers between use of drugs on the Beers list and ]-
240510-Efficacy dementia drugs Drugs avoid …
www.dementiacarestrategies.comMore. . . Copyright © 2008 by Therapeutic Research Center Pharmacist’s Letter / Prescriber’s Letter ~ P.O. Box 8190, Stockton, CA 95208 ~ …
APO-AMOXYCILLIN CAPSULES NAME OF THE …
www.medicines.org.auProduct Information – Australia APO-Amoxycillin Capsules Page 4 achievable; other therapy should be selected. Note: The prevalence of resistance may vary geographically for selected species and local information on
NEW ZEALAND DATA SHEET 1. MAXIGESIC TABLET
www.medsafe.govt.nzNEW ZEALAND DATA SHEET 1. MAXIGESIC TABLET Maxigesic tablet – Paracetamol 500 mg/Ibubrofen 150 mg. 2. QUALITATIVE AND QUANTITATIVE COMPOSITION
Anticholinergics for Overactive Bladder - RxFiles
www.rxfiles.caReferences – RxFiles Newsletter Anticholinergics for Overactive Bladder: Evidence, Clinical Issues and Comparisons (Supplement to the RxFiles Urinary Incontinence Treatment Chart: http://www.rxfiles.ca/acrobat/Cht-urinary-incontinence.pdf )